Reckitt Benckiser Group plc buy Sargnagel
Start price
12.05.15
/
50%
€80.09
Target price
20.12.17
€111.00
Performance (%)
1.98%
End price
20.12.17
€77.33
Summary
This prediction ended on 20.12.17 with a price of €77.33. The BUY prediction by Sargnagel finished with a performance of 1.98%. Sargnagel has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reckitt Benckiser Group plc | 6.647% | 6.647% | -30.321% | -33.769% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
Comments by Sargnagel for this prediction
In the thread Reckitt Benckiser Group plc diskutieren
Produkte für den Haushalt, Gesundheit und mehr
Weltweit tätiger Konzern mit zahlreichen Markenartikeln im Portfolio unter anderem Finish, Lysol, Dettol, Vanish, Woolite, Durex, Calgon, Airwick, Harpic, Bang, Mortein, Veet, Nurofen, Clearasil, Strepsils, Gaviscon, Mucinex, Scholl und French'ster.
Auch der Chartverlauf sieht sehr vielversprechend aus.
(Laufzeit überschritten)
Stopped prediction by Sargnagel for Reckitt Benckiser Group plc
Reckitt Benckiser Group plc
Start price
Target price
Perf. (%)
€77.08
29.01.18
29.01.18
€100.00
04.11.21
04.11.21
-7.76%
05.11.21
05.11.21
